Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar PebbledShore (87.65) Submitted: 7/2/2008 10:22:39 PM : Outperform Start Price: $8.07 OMPI Score: +50.26

What the heck? I need points!

Featured Broker Partners


Advertisement